Novartis AG is 100.6x more valuable than Structure Therapeutics Inc. by market capitalization ($282.64 B vs $2.81 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GPCR | NVS |
|---|---|---|
| Market cap | $2.81 B | $282.64 B |
| US-listed rank | #1858 | #47 |
| Net income (latest FY) | -$141.20M | - |
| SEC filings | 248 | 947 |
Novartis AG is 100.6x more valuable than Structure Therapeutics Inc. by market capitalization ($282.64 B vs $2.81 B).
Full pages: Structure Therapeutics Inc. and Novartis AG, or browse the full rankings.